Cargando…

Indicator opportunistic infections after biological treatment in rheumatoid arthritis, 10 years follow-up in a real-world setting

BACKGROUND: This research describes the incidence and factors associated with opportunistic infections in rheumatoid arthritis (RA) patients treated with biological disease-modifying antirheumatic drugs (bDMARDs). METHODS: A retrospective longitudinal study was carried out from 2007 to 2018. We incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leon, Leticia, Peñuelas, Marina, Candel, Francisco Javier, Freites, Dalifer, Rodriguez-Rodriguez, Luis, Fernandez-Gutierrez, Benjamin, Jover, Juan Angel, Abasolo, Lydia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783660/ https://www.ncbi.nlm.nih.gov/pubmed/31636721 http://dx.doi.org/10.1177/1759720X19878004

Ejemplares similares

Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns
por: Nieto, Maria A., et al.
Publicado: (2021)

Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease
por: Leon, Leticia, et al.
Publicado: (2023)

Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents
por: Fernandez-Gutierrez, Benjamin, et al.
Publicado: (2021)

Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis
por: Freites Nuñez, Dalifer, et al.
Publicado: (2021)

Role of diagnostic imaging in psoriatic arthritis: how, when, and why
por: Crespo-Rodríguez, Ana María, et al.
Publicado: (2021)

Outpatient Readmission in Rheumatology: A Machine Learning Predictive Model of Patient’s Return to the Clinic
por: Madrid-García, Alfredo, et al.
Publicado: (2019)

Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach
por: Lezcano-Valverde, José M., et al.
Publicado: (2017)

RNA sequencing of mesenchymal stem cells reveals a blocking of differentiation and immunomodulatory activities under inflammatory conditions in rheumatoid arthritis patients
por: Lamas, Jose Ramon, et al.
Publicado: (2019)

Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study
por: Nuñez, Dalifer Freites, et al.
Publicado: (2022)

Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA)
por: Freites-Núñez, Dalifer, et al.
Publicado: (2020)

Predictors of health-related quality of life in musculoskeletal disease patients: a longitudinal analysis
por: Madrid-García, Alfredo, et al.
Publicado: (2021)

Influence of colchicine prescription in COVID-19-related hospital admissions: a survival analysis
por: Madrid-García, Alfredo, et al.
Publicado: (2021)

Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
por: Winthrop, K L, et al.
Publicado: (2016)

There and back again: analyzing the effect of outpatient readmission on the quality of life of patients attending a rheumatology clinic
por: Madrid-García, Alfredo, et al.
Publicado: (2021)

A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
por: Regueiro, Cristina, et al.
Publicado: (2020)

Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
por: Bertoldi, Ilaria, et al.
Publicado: (2021)

Real-world retention rates of biologics in patients with rheumatoid arthritis
por: Takami, Kenji, et al.
Publicado: (2023)

Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice
por: Atzeni, Fabiola, et al.
Publicado: (2022)

Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
por: Regueiro, Cristina, et al.
Publicado: (2020)

Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
por: Salaffi, Fausto, et al.
Publicado: (2014)

Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
por: Hirose, Wataru, et al.
Publicado: (2022)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis
por: de Castro, Caroline Tianeze, et al.
Publicado: (2022)

Subcutaneous abatacept in rheumatoid arthritis: A real-life experience
por: Sarmiento-Monroy, Juan Camilo, et al.
Publicado: (2019)

Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2019)

Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
por: Iwamoto, Naoki, et al.
Publicado: (2021)

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
por: Busch, Howard, et al.
Publicado: (2022)

Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2023)

Anxiety, Reinforcement Sensitivity and Social Context in Accepting the Experience of Pain Among Rheumatoid Arthritis Patients
por: Pinel, Luis, et al.
Publicado: (2020)

Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data
por: Simon, Teresa A., et al.
Publicado: (2021)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Real‐World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis
por: Michaud, Kaleb, et al.
Publicado: (2019)

Multidisciplinary approach in the treatment of tendinous foot involvement in rheumatoid arthritis
por: Macarrón Pérez, Pilar, et al.
Publicado: (2021)

Delafloxacin: design, development and potential place in therapy
por: Candel, Francisco Javier, et al.
Publicado: (2017)

Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
por: Grellmann, Claudia, et al.
Publicado: (2020)

Utility of Opportunistic Infections, Joints’ Involvement and Accuracy of Various Screening Tests to Diagnose Rheumatoid Arthritis Patients
por: Ahmad, Ausaf, et al.
Publicado: (2023)

Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region
por: Sun, Xing, et al.
Publicado: (2021)

Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
por: Nozaki, Yuji, et al.
Publicado: (2021)

Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases
por: Leon, Leticia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6njgmsqmbj79m6iiavaks7auo7